TY - JOUR
T1 - Evidence-based self-care guidelines for people receiving chemotherapy
AU - Lewis, L.
AU - Williams, A.M.
AU - Athifa, M.
AU - Brown, D.
AU - Budgeon, C.A.
AU - Bremner, Alexandra
PY - 2015
Y1 - 2015
N2 - © 2015 Wolters Kluwer Health, Inc. Despite numerous evidence-based guidelines (EBGs) being developed to manage the symptom burden associated with cancer and chemotherapy, there is a paucity of research exploring their efficacy. Objective: The aim of this study was to explore the effect of implementing EBGs to reduce the symptom burden and psychological distress of cancer patients requiring outpatient chemotherapy at an acute, tertiary care public hospital in Western Australia. Methods: The study was conducted in 2 populations and stages, using action research to promote change. Stage 1 assessed prevalence; in stage 2, specific EBGs were implemented. Symptom prevalence, severity, and bother were determined at baseline and 1 week and 1 month after initial chemotherapy, to allow comparison between stages. Results: Stage 2 participants did better at managing feeling low (odds ratio, 2.33; 95% confidence interval, 1.47Y3.70; P
AB - © 2015 Wolters Kluwer Health, Inc. Despite numerous evidence-based guidelines (EBGs) being developed to manage the symptom burden associated with cancer and chemotherapy, there is a paucity of research exploring their efficacy. Objective: The aim of this study was to explore the effect of implementing EBGs to reduce the symptom burden and psychological distress of cancer patients requiring outpatient chemotherapy at an acute, tertiary care public hospital in Western Australia. Methods: The study was conducted in 2 populations and stages, using action research to promote change. Stage 1 assessed prevalence; in stage 2, specific EBGs were implemented. Symptom prevalence, severity, and bother were determined at baseline and 1 week and 1 month after initial chemotherapy, to allow comparison between stages. Results: Stage 2 participants did better at managing feeling low (odds ratio, 2.33; 95% confidence interval, 1.47Y3.70; P
U2 - 10.1097/NCC.0000000000000154
DO - 10.1097/NCC.0000000000000154
M3 - Article
C2 - 24945267
VL - 38
SP - E1-E8
JO - Cancer Nursing
JF - Cancer Nursing
SN - 0162-220X
IS - 3
ER -